Testosterone treatment: who will benefit the most?

Linghui Deng¹, Qiu Shi²

Affiliations

¹ National Clinical Research Center of Geriatrics, Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
² Department of Urology, Institute of Urology and Center of Biomedical Big Data, West China Hospital, Sichuan University, Chengdu 610041, China; Institute of Oncology Research, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland. Electronic address: qiushi@scu.edu.cn.

PMID: 37804839
DOI: 10.1016/S2666-7568(23)00191-5

Free article

Comment

Testosterone treatment: who will benefit the most?

Linghui Deng et al. Lancet Healthy Longev. 2023 Oct.

Free article

. 2023 Oct;4(10):e524-e525.

doi: 10.1016/S2666-7568(23)00191-5.

Authors

Linghui Deng¹, Qiu Shi²

Affiliations

¹ National Clinical Research Center of Geriatrics, Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
² Department of Urology, Institute of Urology and Center of Biomedical Big Data, West China Hospital, Sichuan University, Chengdu 610041, China; Institute of Oncology Research, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland. Electronic address: qiushi@scu.edu.cn.

PMID: 37804839
DOI: 10.1016/S2666-7568(23)00191-5

No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis.
Hudson J, Cruickshank M, Quinton R, Aucott L, Wu F, Grossmann M, Bhasin S, Snyder PJ, Ellenberg SS, Travison TG, Brock GB, Gianatti EJ, van der Schouw YT, Emmelot-Vonk MH, Giltay EJ, Hackett G, Ramachandran S, Svartberg J, Hildreth KL, Antonic KG, Tenover JL, Tan HM, Ho Chee Kong C, Tan WS, Marks LS, Ross RJ, Schwartz RS, Manson P, Roberts SA, Skovsager Andersen M, Velling Magnussen L, Aceves-Martins M, Gillies K, Hernández R, Oliver N, Dhillo WS, Bhattacharya S, Brazzelli M, Jayasena CN. Hudson J, et al. Lancet Healthy Longev. 2023 Oct;4(10):e561-e572. doi: 10.1016/S2666-7568(23)00169-1. Lancet Healthy Longev. 2023. PMID: 37804846

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Testosterone treatment: who will benefit the most?

Affiliations

Testosterone treatment: who will benefit the most?

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources